AstraZeneca advances net-zero carbon goals, adding Honeywell deal and outsider oversight among new ESG efforts

Just a few years ago, the pharma industry was labeled as a big-time carbon polluter in a study that showed greenhouse gas emissions that were 55% higher than the auto industry. The study and media reports that followed expressed some shock amid surprisingly scant attention paid...

Click to view original post